Literature DB >> 23957640

Prevention and treatment of hand oedema after stroke.

Stefanie P M Kuppens1, Hanneke C P Pijlman, Minou W M G C Hitters, Caroline M van Heugten.   

Abstract

PURPOSE: As there is no evidence for a specific treatment for post-stroke-induced hand oedema, rehabilitation centre Blixembosch formalized a best practice protocol. We investigated whether the Blixembosch hand oedema protocol is usable in daily practice and leads to lower incidence (prevention) and shorter duration (treatment) compared with care as usual.
METHODS: In a non-randomised comparative trial, we investigated 206 post-stroke patients admitted to two Dutch rehabilitation centres. Hand volumes were measured at least bi-weekly using a volumeter. Treatment was started according the protocol (Blixembosch) or following care as usual (Leijpark). Usability was assessed with a survey among professionals.
RESULTS: In the Blixembosch group, 16% developed oedema after admission, compared with 21% in the control group (p = 0.019). Average duration of oedema (both developed before and after admission) was 6.5 weeks in the Blixembosch group compared with 3.1 weeks in the control group (p = 0.000). Professionals were positive about the protocol.
CONCLUSION: The study showed that the protocol is usable in daily practice and has a small beneficial effect on hand oedema incidence rates compared with care as usual. The negative effect on duration of hand oedema could also be caused by the difference in prognosis between the two groups.

Entities:  

Keywords:  Hand oedema; prevention; rehabilitation; stroke; treatment

Mesh:

Year:  2013        PMID: 23957640     DOI: 10.3109/09638288.2013.824031

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  1 in total

Review 1.  Rehabilitation Interventions for Poststroke Hand Oedema: A Systematic Review.

Authors:  Thuy Anh Giang; Alan Wei Guang Ong; Karthikeyan Krishnamurthy; Kenneth N K Fong
Journal:  Hong Kong J Occup Ther       Date:  2016-06-28       Impact factor: 0.917

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.